GHRP-6 is a synthetic hexapeptide used to study growth hormone release, its interaction with endogenous GHRH, and broader neuroendocrine responses.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Growth hormone secretagogue peptide
GHRP-6 is a six-residue synthetic peptide with non-natural stereochemistry in its sequence. Early papers sometimes call it simply growth hormone-releasing peptide, so the reported structure is important when identifying the compound. It is distinct from GHRH fragments and from other GHRP-family members with similar names.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
As a ghrelin-receptor agonist, GHRP-6 can stimulate GH release through pathways that interact with the hypothalamic–pituitary axis. A human antagonist experiment showed that blocking endogenous GHRH greatly reduced the GH response. This finding argues against treating its action as independent of the broader endocrine regulatory system.
An early study in healthy men measured GH responses and an increase in IGF-1 during repeated experimental exposure. It also detected changes in other hormones, making the paper useful for separating primary GH effects from wider endocrine observations. [1]
Investigators compared GHRP-6 responses with and without a GHRH antagonist in healthy men. The attenuated response helped identify how endogenous GHRH contributes to secretagogue activity, rather than demonstrating a clinical benefit from combining compounds. [2]
A controlled overnight experiment assessed sleep recordings together with GH, ACTH, and cortisol. Stage-2 sleep increased, while slow-wave sleep did not. Concurrent ACTH and cortisol changes complicate any simple description of GHRP-6 as a selective sleep or GH intervention. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The cited human experiments provide direct evidence of short-term biological activity. They principally measure hormonal concentrations and laboratory physiology, with small samples and limited follow-up. Findings from these designs do not establish sustained improvements in growth, sleep disorders, athletic performance, or tissue repair.
The exact sequence and preparation must match the literature. Endocrine responses vary with physiological context, and additional hormone changes may be relevant to interpretation. No cited study verifies the WYZ Labs material or supports transferring experimental observations into personal-use instructions.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Early human experiment identifying the GHRP-6 sequence and measuring several endocrine endpoints.
Antagonist experiment in nine men; evidence about endocrine mechanism.
Overnight physiology study; stage-2 sleep findings did not extend to slow-wave sleep.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
